Teladoc Health, Inc. (TDOC)
| Market Cap | 1.08B -31.3% |
| Revenue (ttm) | 2.49B -2.1% |
| Net Income | -177.40M |
| EPS | -0.99 |
| Shares Out | 181.68M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,933,126 |
| Open | 5.85 |
| Previous Close | 5.81 |
| Day's Range | 5.76 - 5.98 |
| 52-Week Range | 4.40 - 9.89 |
| Beta | 2.14 |
| Analysts | Hold |
| Price Target | 7.59 (+27.14%) |
| Earnings Date | Oct 28, 2026 |
About TDOC
Teladoc Health, Inc. provides virtual healthcare services worldwide. It operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical services, specialty medical, chronic condition management, and mental health services, as well as technologies and enterprise telehealth solutions for hospitals and health systems. Its BetterHelp segment operates a mental health platform that provides online counselling and therapy services through we... [Read more]
Financial Performance
In 2025, Teladoc Health's revenue was $2.53 billion, a decrease of -1.54% compared to the previous year's $2.57 billion. Losses were -$200.32 million, -79.99% less than in 2024.
Financial StatementsAnalyst Summary
According to 23 analysts, the average rating for TDOC stock is "Hold." The 12-month stock price target is $7.59, which is an increase of 27.14% from the latest price.
News
Teladoc Health to Announce Third Quarter 2026 Financial Results
NEW YORK, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Teladoc Health Inc. (NYSE: TDOC), the global leader in virtual care, announced that it will release third quarter 2026 results on Wednesday, October 28, 202...
Teladoc Health Expands Solo Connected Care Platform with AI-Powered Capabilities to Help Hospitals Scale Smarter Care Delivery
New SoloVitals and SoloScribe capabilities bring contactless vitals and ambient documentation directly into clinical workflows New SoloVitals and SoloScribe capabilities bring contactless vitals and a...
Teladoc announces resignation of CLO Vandervoort, Dorfman to succeed
Teladoc (TDOC) Health announced a leadership transition in its legal function. After 11 years with the company, Adam Vandervoort, Chief Legal Officer, CLO, and Secretary, has informed the company of…
Teladoc Health Announces Chief Legal Officer Transition
Jonathan Dorfman to be promoted to Chief Legal Officer and Secretary effective November 2, 2026 Jonathan Dorfman to be promoted to Chief Legal Officer and Secretary effective November 2, 2026
Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08
NEW YORK, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in virtual care, today announced that it issued inducement awards to a new employee.
Teladoc appoints insurance executive Michael Grasher as CFO
Teladoc Health said on Monday it appointed Michael Grasher as its chief financial officer, bringing in an industry veteran to help the virtual healthcare company navigate rising demand for its insur...
Teladoc appoints Michael Grasher as CFO
Teladoc (TDOC) announced the appointment of Michael Grasher as CFO, effective immediately. Grasher most recently served as CFO of IFG Companies, where he was responsible for financial reporting, plann...
Teladoc Health Appoints Michael Grasher as Chief Financial Officer
Appointment brings seasoned financial leadership as Teladoc Health advances its strategy aimed at delivering disciplined, sustainable growth NEW YORK, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Teladoc Health...
Did Teladoc Health, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Shareholders are urged to contact the firm immediately at no cost or obligation, as there may be limited time to enforce your rights. We would handle the matter on a contingent fee basis, whereby yo...
Teladoc put volume heavy and directionally bearish
Bearish flow noted in Teladoc (TDOC) with 1,603 puts trading, or 3x expected. Most active are Aug-26 8 puts and Aug-26 11 calls, with total volume in those strikes near…
Teladoc Health Appoints Financial Executive Mark Anquillare to Its Board of Directors
NEW YORK, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, today announced the appointment of Mark V. Anquillare to its board of directors. Mr. Anquill...
Teladoc price target lowered to $7.50 from $11 at Citi
Citi lowered the firm’s price target on Teladoc (TDOC) to $7.50 from $11 and keeps a Neutral rating on the shares.
Teladoc price target lowered to $8 from $9 at Jefferies
Jefferies analyst Brian Tanquilut lowered the firm’s price target on Teladoc (TDOC) to $8 from $9 and keeps a Hold rating on the shares. Q2 “illustrates the thesis that keeps…
Teladoc price target lowered to $7.50 from $10 at Evercore ISI
Evercore ISI lowered the firm’s price target on Teladoc (TDOC) to $7.50 from $10 and keeps an In Line rating on the shares.
Teladoc tumbles on revenue forecast cut as BetterHelp demand shifts hurt
Teladoc shares fell more than 20% before the bell on Thursday, a day after the virtual healthcare provider trimmed its annual revenue forecast and flagged challenges at its mental health services uni...
Teladoc price target lowered to $10 from $11 at Canaccord
Canaccord lowered the firm’s price target on Teladoc (TDOC) to $10 from $11 and keeps a Buy rating on the shares. The firm said Teladoc had a revenue miss and…
Teladoc Health Earnings Call Transcript: Q2 2026
Q2 results met guidance with Integrated Care outperforming and BetterHelp pressured by a rapid shift from cash pay to insurance, outpacing provider capacity. 2026 revenue guidance was lowered due to cash pay declines, but insurance revenue and margin guidance were reaffirmed. Teladoc One was launched as a new care model.
Teladoc Health Slides: Q2 2026
Teladoc Health has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on July 29, 2026.
Teladoc Health Earnings release: Q2 2026
Teladoc Health released its Q2 2026 earnings on July 29, 2026, summarizing the period's financial results.
Teladoc Health Quarterly report: Q2 2026
Teladoc Health has published its Q2 2026 quarterly earnings report on July 29, 2026.
Teladoc reports Q2 EPS (21c), consensus (22c)
Reports Q2 revenue $606.9M, consensus $616.33M. “We continue to make progress on the priorities we believe are most important to the long-term success of Teladoc (TDOC) Health. Our second-quarter resu...
Teladoc Health Reports Second Quarter 2026 Results
NEW YORK, July 29, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today reported financial results for the three months ended June 30, 2026 (“Second Qua...
Teladoc Health Canada Achieves Accreditation Canada Primer Award, Advancing Quality Standards for Virtual and Hybrid Care in Canada
TORONTO--(BUSINESS WIRE)--Teladoc Health Canada (Teladoc) has achieved the Accreditation Canada Primer Award, providing independent validation of its commitment to delivering safe, high-quality, and p...
Teladoc Health introduces a virtual care practice built around the person, shaping a new era of connected care
Teladoc One is a model of care delivered as a single, predictive and adaptive experience to drive better health outcomes and address the rising total cost of care
Teladoc Health to Announce Second Quarter 2026 Financial Results
NEW YORK, July 15, 2026 (GLOBE NEWSWIRE) -- Teladoc Health Inc. (NYSE: TDOC), the global leader in virtual care, announced that it will release second quarter 2026 results on Wednesday, July 29, 2026,...